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Patients surviving a septic episode exhibit persistent immune impairment and increased
mortality due to enhanced vulnerability to infections. In the present study, using the
cecal ligation and puncture (CLP) model of polymicrobial sepsis, we addressed the
hypothesis that altered vagus nerve activity contributes to immune impairment in sepsis
survivors. CLP-surviving mice exhibited less TNFα in serum following administration of
LPS, a surrogate for an infectious challenge, than control-operated (control) mice. To
evaluate the role of the vagus nerve in the diminished response to LPS, mice were
subjected to bilateral subdiaphragmatic vagotomy at 2 weeks post-CLP. CLP-surviving
vagotomized mice exhibited increased serum and tissue TNFα levels in response to
LPS-challenge compared to CLP-surviving, non-vagotomized mice. Moreover, vagus
nerve stimulation in control mice diminished the LPS-induced TNFα responses while
having no effect in CLP mice, suggesting constitutive activation of vagus nerve signaling
in CLP-survivors. The percentage of splenic CD4+ ChAT-EGFP+ T cells that relay
vagus signals to macrophages was increased in CLP-survivors compared to control
mice, and vagotomy in CLP-survivors resulted in a reduced percentage of ChAT-EGFP+
cells. Moreover, CD4 knockout CLP-surviving mice exhibited an enhanced LPS-induced
TNFα response compared to wild-type mice, supporting a functional role for CD4+
ChAT+ T cells in mediating inhibition of LPS-induced TNFα responses in CLP-survivors.
Blockade of the cholinergic anti-inflammatory pathway with methyllcaconitine, an α7
nicotinic acetylcholine receptor antagonist, restored LPS-induced TNFα responses in
CLP-survivors. Our study demonstrates that the vagus nerve is constitutively active in
CLP-survivors and contributes to the immune impairment.
Keywords: innate immune response, sepsis survivors, vagus tonic activity, CD4+ ChAT+ T cell, TNFα
INTRODUCTION
Sepsis is a potentially lethal illness, triggered in many cases by a gram-negative bacterial infection
(1, 2). It is among the top 10 causes of death in the United States today, with over 750,000 new cases
being diagnosed each year and resulting in 215,000 deaths annually (3). Marked improvements
have been made in decreasing acute mortality in sepsis, but five-year survival rates have remained
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unchanged, irrespective of the age at which a sepsis episode
occurs (4–7). Numerous clinical studies have correlated poor
long-term prognosis in sepsis survivors with both dysregulated
immune cell numbers and function and nosocomial infections,
but the underlying mechanisms that drive these phenomena
are not fully understood (8–11). The systemic inflammatory
response that occurs during acute sepsis is balanced by
an anti-inflammatory response resulting in a prolonged and
profound state of immunosuppression, referred to as a
compensatory anti-inflammatory response syndrome (12). Since
many deaths of sepsis survivors are secondary to infection,
the altered immune response appears to be of clinical
significance (13). The identification of factors and pathways
that contribute to immune dysfunction in sepsis survivors
remains an area of active study (14). A contributing factor is
believed to be profound alterations in monocyte/macrophage
effector cell function that result in failure to appropriately
respond to pathogen challenge with a robust inflammatory
cytokine response (13, 15). Patients surviving sepsis often
exhibit immune anergy, which increases their susceptibility to
infection (16–18). The underlying mechanisms that contribute
to immune anergy and impaired inflammatory responses in
sepsis survivors remain unknown and are the focus of this
study.
The inflammatory reflex is a neural circuit in which
efferent signals transmitted through the vagus nerve regulate
inflammatory cytokine production (19). In acute sepsis, the
inflammatory reflex regulates cytokine production, thereby
preventing potentially damaging inflammation (20). Our
previous work has demonstrated that the inflammatory reflex
inhibits LPS-induced TNFα production in the spleen by
a mechanism requiring neural activation of acetylcholine-
producing T cells (CD4+ ChAT+ T cells) leading to the release
of acetylcholine, which signals through the α7 subunit of the
nicotinic acetylcholine receptor (α7nAChR) expressed on
cytokine-producing macrophages (21). CD4+ ChAT+ T cells are
required for the inhibition of cytokine production by vagus nerve
stimulation. Thus, action potentials originating in the vagus
nerve and transmitted through the splenic nerve regulate CD4+
ChAT+ T cells, which in turn produce the neurotransmitter,
acetylcholine, that is required to control innate immune
responses (21).
In the current study, we demonstrate that in a cecal
ligation and puncture (CLP) mouse model of polymicrobial
sepsis-mediated by gram-negative bacteria, the vagus nerve
is constitutively active in CLP-survivors, impairing their
ability to respond to subsequent challenge by LPS. The
reduction in LPS-induced TNFα observed in sepsis surviving
mice can be partially restored by vagotomy, which severs
the vagus nerve. We further demonstrate that stimulation
of the vagus nerve has no effect on LPS-triggered TNFα
responses in CLP-surviving mice, suggesting that there
is already maximal vagus nerve activity. The constitutive
activation of the vagus nerve in CLP-surviving mice was
associated with an increased frequency of CD4+ ChAT+
T cells.
MATERIALS AND METHODS
Mice
Six-eight week old male BALB/c mice were purchased from
Charles River Laboratories (Wilmington, MA, USA), and
C57BL/6J and CD4 KO (B6.129S2-Cd4tm1Mak/J) mice were
purchased from Jackson Laboratories (Bar Harbor, ME, USA).
ChAT-EGFP (B6.Cg-Tg (RP23-268L19-EGFP) 2Mik/J) mice
were bred at the Feinstein Institute for Medical Research.
All mice were housed under specific pathogen-free conditions
at room temperature (22◦C) and a 12 hr light-dark cycle
with access to chow diet and water. Mice were grouped
randomly and assigned to a specific treatment. Sample sizes
are indicated in figure legends. This study was carried out in
strict accordance with recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes
of Health. The protocols were approved by the Institutional
Animal Care and Use Committee and the Institutional
Biosafety Committee of the Feinstein Institute for Medical
Research.
Cecal Ligation and Puncture and
Endotoxin Challenge
For induction of polymicrobial sepsis, animals were subjected
to CLP, which induces a lethal form of peritonitis associated
with 30–50% mortality (22, 23). Briefly, CLP was performed
under isoflurane anesthesia, and the cecum was isolated and
ligated below the ileocecal valve and then punctured once with
a 22-G needle. Approximately 1mm of feces was extruded, the
cecum was placed back to the abdominal cavity, and then the
abdominal muscle layer was closed with 6.0 DemeSilk sutures
followed by skin layer closure with medical-surgical clips. In
control-operated (control) mice, the cecum was exposed but no
ligation or puncture was performed. Both CLP and control mice
received one dose of antibiotics (imipenem/cilastatin, 0.5 mg/kg
diluted in a 0.9% saline solution) as a part of the resuscitation
fluid (total volume of 0.5 mL/mouse, s.c.) and a single dose of
sterile saline (0.5 mL/mouse, s.c.). Animals were monitored daily
for survival and evaluated using the Mouse Grimace Scale twice
a day for the first 3 days followed by once a day for up to 7 days
after surgery. Methyllycaconitine (MLA) (24) (4 mg/kg; Sigma-
Aldrich, St. Louis, MO, USA) was intraperitoneally administered
30min prior to LPS-challenge in CLP-survivors. Endotoxin (LPS
4 mg/kg from Escherichia coli, 0111: B4; Sigma-Aldrich, St.
Louis, MO, USA) was injected intraperitoneally. Blood and
spleens were harvested at 90min after LPS administration.
Blood was collected via cardiac puncture and serum was
processed within 60min of collection by centrifugation for
15min at 3,000 rpm and 4◦C. Serum samples were stored
at −80◦C until analysis. Spleens were stored in cold-PBS on
ice until cell isolation. TNFα concentrations in serum were
measured by a mouse Proinflammatory 7-plex assay following
the manufacturer’s protocol (Meso Scale Discovery, Rockville,
MD, USA). Plates were analyzed on the MS2400 Imager (Meso
Scale Discovery). Data were quantified by fitting to a standard
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curve using Meso Scale Discovery Workbench software using
default parameters.
Cell Isolation
Spleen cells were analyzed by flow cytometry following the
established protocol at our laboratory. In brief, splenocytes
were isolated by crushing spleen through 70µm strainer in ice
cold-PBS without calcium or magnesium with a 1mL syringe
plunger. Cell pellets were resuspended in red blood cell lysis
buffer (BioLegend, San Diego, CA, USA) for 5min at room
temperature, and washed twice with 2% fetal bovine serum (FBS)
containing PBS and counted.
Ex vivo LPS Stimulations
Single-cell suspensions of splenocytes (6 × 106 cells/mL) were
cultured in flat-bottomed 96-well plates for 24 h in 200 µL RPMI
medium supplemented with 10% FBS, 100 U/ mL penicillin and
100µg/mL streptomycin (Gibco, Gaithersburg, MD, USA). Cells
were cultured in medium alone or in medium containing LPS
from E. coli (100 ng/mL; Serotype R515 (Re) TLR grade; Enzo,
Farmingdale, NY, USA). Supernatants from cultured splenocytes
were stored at−80◦C until analysis.
Flow Cytometry
For flow cytometry, one million cells per sample were first
blocked with Fc block (Rat anti-mouse CD16/CD32, BD
Biosciences, San Jose, CA, USA) for 5min at room temperature.
Cells were then incubated with phycoerythrin (PE)-Cy7-
conjugated rat anti-mouse CD11b (BD Biosciences); fluorescein
isothiocyanate (FITC)-conjugated rat anti-mouse Ly6C (BD
Biosciences); allophycocyanin (APC)-conjugated rat anti-mouse
CD62L (BioLegend); PE-conjugated rat anti-mouse CD4 (BD
Biosciences); pacific blue-conjugated rat anti-mouse CD44
(BioLegend) antibodies and Fixable Viability Dye efluor506
(Thermo Fisher Scientific, Waltham, MA, USA) for 30min at
4◦C. The cells were fixed in 1% paraformaldehyde and kept in the
dark at 4◦Cuntil analysis. Data were acquired using an LSRII flow
cytometer (BD Biosciences) and analyzed with FlowJo software
(Tree Star, Inc., Ashland, OR, USA).
Immunofluorescence
Spleens were fresh-frozen with dry ice, embedded in O.C.T.
compound (Tissue-Tek; Thermo Fisher Scientific), and kept at
−80◦C until processing. Spleen slices were cut at 10µm thickness
using a Leica3050s cryostat (Leica Biosystems Inc., IL, USA)
and air-dried on glass slides. All incubations were performed at
room temperature in a humidified chamber. Slides were fixed
in 4% paraformaldehyde (Sigma Aldrich, St. Louis, MO, USA)
for 10min and permeabilized in 1% cytofix/cytoperm solution
(BD Biosciences) for 30min. PE-conjugated rat anti-mouse
TNFα antibody (eBiosciences) was diluted (1:50 dilution) in 1%
cyto/perm solution. After a 2 h incubation period, the slides were
washed three times in PBS containing 0.05% Tween 20, dried
and mounted in Dako fluorescence mounting medium (Santa
Clara, CA, USA). Slides were observed through a Zeiss LSM880
Confocal microscope. Images were analyzed and quantified by
using the ZenBlue software (Zeiss, Oberkochen, Germany).
Vagotomy
For vagotomy experiments, vagotomy was performed under
isoflurane anesthesia at 2 weeks post-CLP or control surgery.
The subdiaphragmatic vagus nerve was exposed from the ventral
aspect and both the ventral and dorsal branch of the vagus nerves
were dissected (25). For non-vagotomized mice, the vagus nerve
was gently exposed without further manipulation. Mice were
administered 0.5mL sterile saline to aid recovery from surgery.
Animals were monitored for 7 days.
Electrical stimulation of the Vagus Nerve
Male BALB/c mice were anesthetized with 100 mg/kg ketamine
and 10 mg/kg xylazine i.p. Vagus nerve stimulation (VNS) was
performed as described previously (26). In brief, a ventral midline
cervical incision wasmade and the left carotid sheath was isolated
between the sternomastoid and sternohyoid muscles. A custom-
built bipolar cuff electrode (MicroProbes, Gaithersburg, MD,
USA) with a silastic coated platinum-iridium wire lead and an
internal diameter of 0.3mm was held about the outside of the
entire carotid sheath containing the vagus nerve. In mice without
vagus nerve stimulation, the left carotid sheath was exposed,
but not stimulated. Electrical pulses (biphasic, 0.75mA current
output, 0.25ms pulse width, 10Hz frequency, 60 s pulse train)
were delivered by a custom-built stimulator (SetPoint Medical
Inc., Valencia, CA, USA). Each mouse was allowed to recover
from anesthesia for 3 hr and after that injected with LPS (4mg/kg;
i.p.). Mice were euthanized 90min after LPS injection, and serum
was obtained for TNFα determination.
Statistical Analysis
Statistical analysis was performed with GraphPad Prism 5
(GraphPad Inc., La Jolla, CA, USA) using the Mann-Whitney U
test (two groups) or Tukey’s post hoc one-way ANOVA (three or
more groups) and p-values < 0.05 were considered significant.
RESULTS
Constitutive Activation of the Vagus Nerve
in Sepsis Surviving Mice Impairs Their
Ability to Respond to LPS-challenge
To confirm previous studies demonstrating a blunted innate
immune response in sepsis surviving mice, we challenged
control and CLP-surviving mice with LPS administered by
intraperitoneal injection 4 weeks post-surgery. CLP-survivors
mounted a diminished TNFα response compared to control
mice (Figure 1A). To evaluate whether there was an intrinsic
alteration in monocyte/macrophage responsiveness to LPS,
splenocytes were isolated from control and CLP-surviving mice
and stimulated with LPS ex vivo. Consistent with a prior
report (27), splenocytes isolated from sepsis surviving mice
were responsive to LPS stimulation showing increased secretion
of TNFα compared to splenocytes from control mice when
stimulated with LPS ex vivo (Supplementary Figure 1). Taken
together, these findings suggested that the reduced response
to LPS challenge in vivo reflected an inhibitory effect of
cellular networks within the spleen. It is well established that
the vagus nerve regulates TNFα production by macrophages
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FIGURE 1 | Vagotomy restores LPS-induced TNFα response in CLP-survivors. To assess the in vivo immune response of CLP-surviving mice to subsequent LPS
challenge, BALB/c mice were subjected to control or CLP surgery, allowed to recover for 4 weeks, and then administered LPS (4 mg/kg) by intraperitoneal injection.
Vagotomy (VGX) was performed 2 weeks post-CLP or control surgery. Blood and spleens were harvested 90min after LPS administration. (A) Lower TNFα levels in
serum of sepsis survivors in response to LPS challenge in vivo. (n = 8 mice/group). Results are the mean ± SEM from two independent experiments, Control + LPS
vs. CLP + LPS ***p < 0.001 (Tukey’s post hoc test). (B) Restoration of LPS-induced TNFα responses following bilateral subdiaphragmatic vagotomy in sepsis
survivors. (n = 8–19 mice/group). Results are the mean ± SEM from three independent experiments, CLP VGX− vs. CLP VGX+ *p < 0.05 and Control VGX− vs. CLP
VGX− ***p < 0.001 (Tukey’s post hoc test). (C) Anatomical localization of splenic LPS-induced TNFα in sepsis survivors. (n = 5–7 mice/group). Results are the mean
± SEM from two independent experiments, CLP VGX− + LPS vs. CLP VGX+ + LPS *p < 0.05; Control without LPS vs. Control + LPS or Control + LPS vs. CLP
VGX− + LPS ***p < 0.001 (Tukey’s post hoc test). Magnification: (20X; scale bar = 50µm). (D) Mice were subjected to with or without vagus nerve stimulation (VNS;
1min) followed by LPS injection. Serum TNFα was measured by ELISA. (n = 11–16 mice/group). Results are the mean ± SEM from two independent experiments,
Control VNS− vs. Control VNS+ **p < 0.01; CLP VNS− vs. CLP VNS+ ns = not significant (Tukey’s post hoc test).
in the spleen (28). Therefore, we hypothesized that the
splenic microenvironment and/or altered vagus nerve activity
contributes to an altered in vivo monocyte/ macrophage
response to LPS. To evaluate the impact of the vagus nerve
on the diminished TNFα production in CLP-surviving mice,
CLP-surviving and control mice were subjected to bilateral
subdiaphragmatic vagotomy (VGX+) or non-vagotomy (VGX−)
two weeks post-CLP surgery. Two weeks after vagotomy, LPS was
administered to the mice and serum TNFα levels were evaluated.
We again observed significantly lower LPS-induced TNFα levels
in the CLP-surviving, non-vagotomized (CLP VGX−) cohort
compared to the control non-vagotomized (Control VGX−)
cohort, as expected (Figure 1B). In sharp contrast, CLP-surviving
vagotomized (CLP VGX+) mice exhibited significantly increased
serum TNFα levels in response to LPS injection compared to
CLP VGX− mice (Figure 1B). There was no difference between
control VGX− mice and control VGX+ mice (Figure 1B).
To confirm that the serum response reflects the activation of
cells within the spleen, we also performed immunofluorescence
analyses of the LPS-induced TNFα expression in the spleen
sections from control mice, and CLP VGX− and CLP VGX+
mice. Strong TNFα staining was observed in spleen sections
from LPS-challenged control mice (Figure 1C, upper right
panel) while negligible TNFα staining was observed in LPS-
challenged CLP VGX− mice (Figure 1C, lower left panel),
consistent with differences observed in serum TNFα levels. As
in the blood, TNFα immunoreactivity was partially restored
in spleen sections of LPS-challenged CLP VGX+ compared
to CLP VGX− mice (Figure 1C, lower right panel). These
data suggest that the vagus nerve is modulating LPS-triggered
TNFα responses in CLP-surviving mice and is consistent with
previous data showing that vagus nerve stimulation results
in attenuated TNFα expression in LPS-challenged naive mice
(28).
Vagus Nerve Stimulation Fails to Lower
LPS-induced Serum TNFα Levels in
CLP-surviving Mice
We next tested whether vagus nerve stimulation would alter LPS-
induced TNFα levels in CLP-surviving mice as it is reported
to do in mice that have not undergone CLP surgery. While
electrical stimulation of the vagus nerve in control mice
significantly (p< 0.01) decreased LPS-induced serum TNFα
levels as expected, it had no significant effect on LPS-induced
serum TNFα levels in CLP mice (Figure 1D). This finding is
consistent with our hypothesis that vagus nerve signaling is
constitutively active in CLP-surviving mice.
Vagotomy Does Not Alter the Number of
Myeloid Cells in the Spleen of Sepsis
Survivors
As previously shown (23), a marked expansion of the
myeloid compartment occurs in CLP mice (Supplementary
Figures 2A,B). There were significant increases in
CD11b+Ly6Chigh and CD11b+ Ly6Clow myeloid populations in
the spleen at two (p< 0.001) and four (p< 0.01) weeks post-CLP
compared to control mice (Supplementary Figures 2A,B).
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Similar increases in CD11b+Ly6Chigh and CD11b+ Ly6Clow
were observed in bone marrow and blood at 2 weeks post-CLP
(data not shown). To address whether the effect of vagotomy
might be due, at least in part, to changes in the number of
monocyte/macrophage populations in the spleen of sepsis
survivors, we quantified splenic monocytes/macrophages from
CLPVGX− andCLPVGX+mice4weekspost-surgery.Vagotomy
did not significantly alter the total number of spleen cells or
the number of CD11b+Ly6Chigh or CD11b+Ly6Clow myeloid
populations in CLP mice (Supplemental Figure 2C), suggesting
that the changes in serum TNFα levels observed in vagotomized
mice were not the result of an expandedmonocytes/macrophages
population.
Vagus Nerve Tonic Activity Increases
Acetylcholine-Producing T Cell Numbers in
Sepsis Survivors
Previous studies have shown that one mechanism by which
the nervous system can regulate immune responses is through
the actions of ChAT+ T cells that are a subset of memory
CD4+ T cells (CD62Llow; CD44high) (21). Stimulation of the
vagus nerve initiates a sequence of events that culminates in
the release of acetylcholine by ChAT+ T cells, which acts on
α7 nicotinic receptors on myeloid cells to suppress LPS-induced
TNFα responses (21). Based on our observation that vagus
nerve stimulation failed to downregulate the in vivo response to
LPS-challenge in CLP-surviving mice, we sought to determine
whether the numbers of ChAT+ T cells differed in the spleens
of control and CLP mice. For these cell quantification studies, we
used ChAT-EGFP mice which express EGFP under the control
of transcriptional regulatory elements for ChAT, the enzyme
that catalyzes the biosynthesis of acetylcholine. Flow cytometry
revealed that the percentage of splenic ChAT-EGFP+ cells among
memory CD4+ CD44highCD62Llow T cells was increased in CLP
mice compared to control mice (8.12± 0.43% Control VGX− vs.
19.9± 2.36% CLP VGX−; SEM), and ablation of vagus signals by
vagotomy in CLP mice resulted in a decrease in the percentage
of ChAT-EGFP+ cells among memory T cells (19.9 ± 2.36%
CLP VGX− vs. 14.4 ± 1.11% CLP VGX+; SEM) (Figures 2A,B).
Moreover, the numbers of splenic ChAT-EGFP+ cells among the
memory population was also increased in CLP mice compared
to control mice (Control VGX− 0.145 ± 0.019 vs. CLP VGX−
0.491 ± 0.143 × 106 cells/ spleen; SEM) while CLP VGX+ mice
exhibited reduced numbers of ChAT-EGFP+ cells (CLP VGX−
0.491 ± 0.143 vs. CLP VGX+ 0.226 ± 0.046 × 106 cells/ spleen;
SEM) (Supplementary Figure 3). These observations suggest
constitutive vagus nerve activation in CLP-surviving mice.
Vagus Nerve Endogenous Activity Requires
CD4T Cells to Mediate Inflammatory
Reflex
To confirm a functional role of CD4+ ChAT+ T cells in
mediating the reduction in the LPS-triggered TNFα response,
CD4T cell-deficient and wild-type (WT) C57BL/6J mice were
subjected to CLP surgery. LPS-triggered serum TNFα levels were
significantly enhanced in CLP CD4-deficient mice compared to
CLPWTmice (Figure 3A). Increased numbers of TNFα positive
cells were observed in spleens of CLP CD4-deficient mice,
paralleling changes observed in serum TNFα levels (Figure 3B).
Pharmacological Blockade of Vagus Nerve
Signaling Restores LPS-Triggered TNFα
Responses in CLP Mice
We next employed pharmacologic blockade of the α7nAChR
to confirm that suppression of LPS-triggered TNFα responses
in sepsis surviving mice occurs through the cholinergic
pathway. CLP-surviving mice were treated with MLA, an
α7nAChR antagonist (29), or vehicle at four weeks post-CLP.
Pharmacologic inhibition of the α7nAChR with MLA led to a
significant increase in LPS-induced TNFα levels in CLP mice
compared to saline treated-CLP mice (Figure 4A). Consistent
with the increase in serum TNFα levels, MLA treatment
significantly enhanced the number of TNFα positive cells in
the spleen (Figure 4B). Together, these data suggest that altered
cholinergic tone is mediating its effects through α7nAChR.
DISCUSSION
Using an experimental model of sepsis, we have explored the
mechanisms that trigger immune dysfunction in sepsis surviving
hosts. We have demonstrated that in sepsis survivors, inhibitory
signals from the brain to the immune system are chronically
active. We have further demonstrated that if we surgically cut the
vagus nerve that transmits these signals, or if we use drugs that
block vagus nerve signaling, we can restore immune function.
This study is of clinical significance as patients surviving severe
sepsis exhibit persistent immune dysfunction and an inability
to effectively control subsequent infections, which contributes
to poor long-term outcomes. In fact, sepsis survivors have
dramatically increased mortality rates within 5 years of the
septic episode that are attributable, at least in part, to immune
dysfunction (13, 30, 31). Several reports have identified that
monocytes exposed to a septic insult or to a high dose of
LPS exhibit decreased production of TNFα and other cytokines
upon rechallenge with LPS (32, 33). Here we demonstrate
that reduced TNFα responses following LPS-challenge in CLP-
survivors are due in part to altered monocyte/macrophage
function in the spleen. Paradoxically, splenic monocytes/
macrophages in CLP mice that are hyporesponsive to LPS-
challenge in vivo generate a robust TNFα response upon
exposure to LPS ex vivo suggesting that hyporesponsiveness
in vivo derives from signals within the microenvironment.
Previous studies have shown that vagus nerve stimulation
using electrical or pharmacological approaches in models of
endotoxemia and sepsis results in suppression of LPS-induced
TNFα production in splenic macrophages through activation
of the cholinergic anti-inflammatory pathway (28, 34, 35). The
role of the vagus nerve in mediating immune suppression
was confirmed in the present study as surgical ablation of
vagus nerve signals by subdiaphragmatic vagotomy led to the
restoration of LPS-triggered TNFα production (Figures 1B,C).
Importantly, enhanced TNFα production in vagotomized CLP
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FIGURE 2 | Vagus nerve signaling increases the number of ChAT+ memory T cells in CLP-survivors. To determine the number of ChAT+ T cells, ChAT-EGFP mice
were subjected to control or CLP surgery. Vagotomy was performed 2 weeks post control and CLP surgery. Splenocytes isolated from CLP or control mice at 4
weeks post-surgery were stained for CD4, CD44, and CD62L and analyzed by flow cytometry. (A) Representative dot plots depicting the gating strategy for splenic
CD44 and CD62L expression in CD4+ T cells and ChAT-EGFP expression in CD4+ CD44highCD62Llow cells. (B) The percentage of ChAT-EGFP+ cells among
spleen CD4+ CD44highCD62Llow cells. Results represent the mean ± SEM of 5–11 mice per group from two independent experiments; CLP VGX− vs. CLP VGX+
*p < 0.05; Control VGX− vs. CLP VGX− ***p < 0.001 and Control VGX− vs. Control VGX+ ns = not significant (Tukey’s post hoc test).
FIGURE 3 | CD4T cell-deficiency restores LPS-induced TNFα responses in CLP-survivors. To identify the role of CD4+ T cells in mediating inflammatory reflex,
C57BL6/J WT and CD4 knockout mice were subjected to CLP surgery, allowed to recover for 4 weeks, and then challenged with LPS by intraperitoneal injection
(6 mg/kg). Blood and spleens were harvested 90min after LPS administration. Serum TNFα was measured by ELISA. (A) Enhanced LPS-induced serum levels of
TNFα in endotoxemic CD4T cell-deficient CLP-surviving mice. Results represent the mean ± SEM of 6–7 mice per group from one of two independent experiments;
CLP WT + LPS vs. CLP CD4 KO + LPS *p < 0.05. (Mann-Whitney U-test). (B) TNFα staining in spleen sections of CLP WT and CLP CD4 KO. Magnification (20X;
scale bar = 50µm). Images are representative of spleen sections from two independent experiments (n = 7). CLP WT + LPS vs. CLP CD4 KO + LPS ***p < 0.001.
(Mann-Whitney U-test).
mice is not the result of altered numbers of inflammatory
monocytes in the spleen as inflammatory monocyte numbers
were equivalent in vagotomized and non-vagotomized CLP-
survivors.
Studies by others have demonstrated that vagus nerve
stimulation activates the adrenergic splenic nerve to release
norepinephrine, which then binds to β2 adrenergic receptors
expressed on CD4+ ChAT+ T cells that express choline
acetyltransferase, the rate-limiting enzyme in acetylcholine
biosynthesis (21, 28). In the present study, we show that
the immunosuppressive effects of constitutive vagus nerve
activation in sepsis surviving mice are mediated through
an increased number of CD4+ ChAT+ T cells (Figure 2).
Moreover, enhanced endogenous cholinergic tonic activity in
CLP-surviving mice failed to attenuate TNFα production in
CD4-deficient mice, suggesting that CD4+ ChAT+ T cells are
indispensable to mediate the inflammatory reflex (Figure 3).
Reciprocally, vagus nerve stimulation failed to suppress TNFα
release in response to LPS-challenge in CLP mice (Figure 1).
The failure to respond to vagus nerve stimulation might
reflect an impairment in (1) nerve transduction, (2) the
response of acetylcholine-producing T cells in the spleen
to norepinephrine released by the splenic nerve or (3) the
response of splenic monocytes to acetylcholine engagement
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FIGURE 4 | Methyllycaconitine treatment restores LPS-induced TNFα responses in CLP-survivors. BALB/c mice were subjected to control and CLP surgery, allowed
to recover for 4 weeks, and then treated by intraperitoneal injection with methylcaconitine (MLA; 4 mg/kg) or vehicle (saline) 30min prior to LPS-challenge (4 mg/kg).
Blood and spleens were harvested 90min after LPS administration. Serum TNFα was measured by ELISA. (A) Enhanced LPS-induced serum levels of TNFα in
endotoxemic MLA-treated CLP-surviving mice. Results represent the mean ± SEM of 6–9 mice per group from two independent experiments; CLP + Saline + LPS
vs. CLP + MLA + LPS **p < 0.01. (Mann-Whitney U-test). (B) TNFα staining in spleen sections of CLP + Saline + LPS and CLP + MLA + LPS. Magnification (20X;
scale bar = 50µm). Images are representative of spleen sections from two independent experiments (n = 6). CLP + Saline + LPS vs. CLP + MLA + LPS **p < 0.01.
(Mann-Whitney U-test).
FIGURE 5 | Enhanced vagus nerve signaling effects on LPS-induced TNFα in CLP-survivors. (A) Increased vagus nerve signaling leads to activation of the higher
number of acetylcholine-producing T cells (ChAT+ T cells) in the spleen. Subsequent activation of α7 nicotinic acetylcholine receptor (α7AchR) on
monocytes/macrophages leads to an inability to further suppress LPS-induced TNFα. (B) The cholinergic tone determines the immune balance, shifting between
enhanced vagus nerve activation leading to an immunosuppressed phenotype and decreased vagus nerve activation leading to restored immunocompetence.
of α7 receptors, or it might reflect tonic activity of the
vagus nerve and an inability to exhibit a further decrease in
response to vagus nerve stimulation (36). It has been shown
previously that the α7nAChR is required for acetylcholine-
mediated inhibition of TNFα release by splenic macrophages
(37); the suppressive effect of vagus nerve stimulation on TNFα
production is lost in α7nAChR-deficient mice (37). In this
study, pharmacological blockade of α7nAChR abrogated the
suppression of TNFα, confirming that the cholinergic tone in
CLP mice was responsible for the attenuated response to LPS
(Figure 4).
In conclusion, we have shown here that enhanced vagus nerve
tonic activity leads to an immunosuppressed phenotype in sepsis
survivors due to increased numbers of ChAT+ T cells (Figure 5).
Further work needs to be done to determine whether other
immune and metabolic changes observed in sepsis survivors
result from constitutive activation of the vagus nerve, or whether
this mechanism selectively regulates the inflammatory response.
It will also be critical to confirm that these pathways are active
in patients who survive sepsis. Our findings reveal that vagus
nerve activation which can acutely suppress inflammation can
also mediate chronic immunosuppression as is observed in sepsis
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surviving mice. Since vagus nerve signaling/cholinergic tone can
be pharmacologically modulated, such treatments in patients
who survive sepsis could represent a novel approach to prevent
subsequent infections in this group.
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